rs6532244

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_005506.4(SCARB2):​c.117+8702G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.449 in 151,866 control chromosomes in the GnomAD database, including 16,584 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.45 ( 16584 hom., cov: 31)

Consequence

SCARB2
NM_005506.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.277

Publications

3 publications found
Variant links:
Genes affected
SCARB2 (HGNC:1665): (scavenger receptor class B member 2) The protein encoded by this gene is a type III glycoprotein that is located primarily in limiting membranes of lysosomes and endosomes. Earlier studies in mice and rat suggested that this protein may participate in membrane transportation and the reorganization of endosomal/lysosomal compartment. The protein deficiency in mice was reported to impair cell membrane transport processes and cause pelvic junction obstruction, deafness, and peripheral neuropathy. Further studies in human showed that this protein is a ubiquitously expressed protein and that it is involved in the pathogenesis of HFMD (hand, foot, and mouth disease) caused by enterovirus-71 and possibly by coxsackievirus A16. Mutations in this gene caused an autosomal recessive progressive myoclonic epilepsy-4 (EPM4), also known as action myoclonus-renal failure syndrome (AMRF). Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
SCARB2 Gene-Disease associations (from GenCC):
  • action myoclonus-renal failure syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
  • progressive myoclonus epilepsy
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, PanelApp Australia
  • Unverricht-Lundborg syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.896 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005506.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCARB2
NM_005506.4
MANE Select
c.117+8702G>T
intron
N/ANP_005497.1Q14108-1
SCARB2
NM_001204255.2
c.117+8702G>T
intron
N/ANP_001191184.1Q14108-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCARB2
ENST00000264896.8
TSL:1 MANE Select
c.117+8702G>T
intron
N/AENSP00000264896.2Q14108-1
SCARB2
ENST00000640634.1
TSL:5
c.93+8702G>T
intron
N/AENSP00000492737.1A0A1W2PRS1
SCARB2
ENST00000862445.1
c.117+8702G>T
intron
N/AENSP00000532504.1

Frequencies

GnomAD3 genomes
AF:
0.448
AC:
68053
AN:
151748
Hom.:
16541
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.558
Gnomad AMI
AF:
0.567
Gnomad AMR
AF:
0.457
Gnomad ASJ
AF:
0.467
Gnomad EAS
AF:
0.918
Gnomad SAS
AF:
0.522
Gnomad FIN
AF:
0.362
Gnomad MID
AF:
0.313
Gnomad NFE
AF:
0.351
Gnomad OTH
AF:
0.425
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.449
AC:
68157
AN:
151866
Hom.:
16584
Cov.:
31
AF XY:
0.452
AC XY:
33558
AN XY:
74222
show subpopulations
African (AFR)
AF:
0.558
AC:
23117
AN:
41392
American (AMR)
AF:
0.458
AC:
6983
AN:
15242
Ashkenazi Jewish (ASJ)
AF:
0.467
AC:
1616
AN:
3464
East Asian (EAS)
AF:
0.918
AC:
4742
AN:
5168
South Asian (SAS)
AF:
0.521
AC:
2504
AN:
4806
European-Finnish (FIN)
AF:
0.362
AC:
3819
AN:
10538
Middle Eastern (MID)
AF:
0.330
AC:
97
AN:
294
European-Non Finnish (NFE)
AF:
0.351
AC:
23859
AN:
67950
Other (OTH)
AF:
0.430
AC:
906
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1807
3614
5420
7227
9034
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
624
1248
1872
2496
3120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.389
Hom.:
15726
Bravo
AF:
0.461
Asia WGS
AF:
0.711
AC:
2470
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
4.7
DANN
Benign
0.55
PhyloP100
0.28
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6532244; hg19: chr4-77125878; API